Retention in Care among Patients with Early HIV Disease in Haiti
暂无分享,去创建一个
J. Pape | S. Koenig | P. Cremieux | J. Dévieux | V. Rivera | K. Hennessey | B. Charles | M. McNairy | A. Marcelin | C. Guiteau | Taina Dadaille Leger | Yvel Marcelin
[1] B. Williams,et al. CD4 Cell Count: Declining Value for Antiretroviral Therapy Eligibility. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] C. Fraser,et al. CD4+ cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar time. , 2015 .
[3] R. Brookmeyer,et al. Simplified HIV Testing and Treatment in China: Analysis of Mortality Rates Before and After a Structural Intervention , 2015, PLoS medicine.
[4] H. Lane,et al. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. , 2015, The New England journal of medicine.
[5] R. Salamon,et al. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. , 2015, The New England journal of medicine.
[6] P. Farmer,et al. Factors Impacting the Provision of Antiretroviral Therapy to People Living with HIV: The View from Haiti , 2014, Antiviral therapy.
[7] J. Pape,et al. The Haiti Research-Based Model of International Public Health Collaboration: The GHESKIO Centers , 2014, Journal of acquired immune deficiency syndromes.
[8] M. Bassett,et al. WHO's new guidelines for antiretroviral treatment , 2013, The Lancet.
[9] Anne M Johnson,et al. Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm³: assessment of need following changes in treatment guidelines. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] Lei Wang,et al. Prevention of HIV-1 infection with early antiretroviral therapy. , 2011, The New England journal of medicine.
[11] S. Rosen,et al. Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review , 2011, PLoS medicine.
[12] Till Bärnighausen,et al. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. , 2014, The Lancet. Global health.